Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding Il33 And Il1Rl1 - EP3957752
EP3957752
- Filing Date
- Mar 20, 2018
- Status
- Granted
- Grant Date
- Aug 20, 2025
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP3957752B1 was granted to Regeneron Pharmaceuticals on Aug 20, 2025 following the initial filing on Mar 20, 2018 under the application number The current legal status of the patent is Granted.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents